HomeNDRA • NASDAQ
add
ENDRA Life Sciences Inc
Previous close
$4.65
Day range
$4.30 - $4.72
Year range
$2.90 - $11.96
Market cap
5.82M USD
Avg Volume
204.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.62M | -62.25% |
Net income | -3.17M | 23.62% |
Net profit margin | — | — |
Earnings per share | -2.23 | -108.87% |
EBITDA | -1.61M | 62.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 762.36K | -76.39% |
Total assets | 3.85M | -13.44% |
Total liabilities | 1.59M | -15.77% |
Total equity | 2.26M | — |
Shares outstanding | 1.24M | — |
Price to book | 2.42 | — |
Return on assets | -139.40% | — |
Return on capital | -235.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.17M | 23.62% |
Cash from operations | -1.61M | -6.33% |
Cash from investing | -3.00M | — |
Cash from financing | 4.58M | — |
Net change in cash | -31.67K | 97.91% |
Free cash flow | -4.29M | -64.97% |
About
Founded
2008
Headquarters
Website
Employees
21
